NASDAQ:VERU - Veru Inc.
$3.68
 $-0.61
-14.22%
4:00PM EDT
2020-01-24
Veru Inc., formerly The Female Health Company, incorporated on February 4, 1971, is a therapeutics company focused on developing and commercializing pharmaceuticals and devices in men's and women's health and oncology. The Company is engaged in the development, manufacture and marketing of consumer healthcare products. The Company has three divisions: Pharmaceutical and Devices, Consumer Health Products and Public Sector. For men, product and product candidates are in the areas of benign prostatic hyperplasia (BPH), male infertility, amelioration of side effects of hormonal prostate cancer therapies, prostate cancer, gout and sexual dysfunction. Women's Health has product candidates for female sexual health, and advanced breast and ovarian cancers. The Company manufactures, markets and sells the FC2 Female Condom. FC2 provides dual protection against unintended pregnancy and sexually transmitted infections (STIs), including human immunodeficiency virus/acquired immune deficiency syndrome (HIV/AIDS). The Company's first generation product is the FC1 Female Condom, a Class III medical device and second generation product is FC2. FC2's primary use is for disease prevention and family planning, and the public health sector is the Company's main market.The Pharmaceutical and Devices division is engaged in the development of products through a combination of internal, collaborative and outsourced programs. Read more at  reuters.com
sector:  health care
industry:  pharmaceuticals
the data below are updated and published after 9pm EDT each trading day
  VERU     avg for
industry  
  avg for
sector  
42 stocks weight:  1. 70 K 205. 33   254. 10  
42 stocks rank:  4. 00   1. 77 K 1. 52 K
# analyst opinions:  4. 00   10. 17   13. 83  
mean recommendation:  1. 70   2. 03   2. 04  

quick ratio:  0. 81   1. 50   1. 98  
current ratio:  1. 20   1. 94   2. 46  

ex-dividend date:     2014-04-27
target price low:  4. 50   79. 80   127. 29  
target price avg:  7. 38   92. 87   151. 36  
target price high:  12. 00   104. 11   171. 54  
1-yr high:  4. 74   90. 81   150. 82  
last close:  4. 56   87. 31   142. 91  
50-day avg:  2. 83   83. 05   136. 56  
200-day avg:  2. 16   77. 77   125. 55  
1-yr low:  1. 18   65. 91   103. 11  
volume:  258. 07 K 6. 40 M 4. 11 M
50-day avg volume:  341. 03 K 5. 75 M 3. 84 M
200-day avg volume:  208. 65 K 6. 32 M 4. 10 M

1-day return:  0. 00 % -0. 13 % 0. 07 %
this week return:  11. 22 % -0. 16 % 0. 14 %
12-wk return:  131. 47 % 12. 25 % 12. 98 %
52-wk return:  203. 70 % 24. 60 % 24. 27 %

enterprise value (EV):  278. 34 M 190. 77 B 132. 01 B
market cap:  278. 37 M 2. 50 T 5. 99 T
EBITDA:  -5. 96 M 11. 51 B 8. 27 B
enterprise multiple (EV/EBITDA):  -46. 67   9. 56   5. 14  
enterprise/revenue (EV/R):  8. 75   8. 32   14. 64  
total revenue:  31. 80 M 33. 38 B 42. 10 B
total debt:  12. 12 M 20. 56 B 18. 20 B
debt/equity:  37. 48   108. 31   102. 19  
net income (common):  -12. 02 M 5. 81 B 4. 20 B

shares outstanding:  65. 04 M 2. 24 B 1. 23 B
shares:  47. 13 M 2. 16 B 1. 19 B
shares short:  114. 31 K 20. 05 M 13. 98 M
shares short prior month:  54. 03 K 21. 38 M 14. 75 M
short ratio:  0. 27   3. 67   4. 21  
short % of float:  0. 25 % 1. 87 % 2. 87 %
total cash/share:  0. 10   4. 51   10. 06  
total cash:  6. 30 M 7. 99 B 6. 82 B
free cash flow:  -6. 01 M 8. 48 B 5. 60 B
operating cash flow:  -5. 49 M 8. 72 B 6. 50 B

book value:  0. 50   17. 96   28. 70  
price/book:  9. 18   9. 65   8. 27  
gross profits:  21. 66 M 68. 90 B 36. 52 B
operating margins:  -20. 24 % -85. 39 % -122. 81 %
EBITDA margins:  -18. 75 % 29. 83 % 22. 50 %
profit margins:  -37. 79 % 19. 33 % 12. 83 %
gross margins:  68. 10 % 68. 96 % 55. 66 %

1-yr max volatility:  13. 17 % --- ---
1-yr mean volatility:  2. 58 % 0. 99 % 1. 16 %

1-yr EPS:  -0. 19   2. 27   4. 37  
forward EPS:  -0. 02   5. 03   7. 26  
P/E:  -24. 00   24. 41   24. 55  
forward P/E:  -209. 50   17. 31   19. 48  
PE/G:  -0. 14   -0. 44   1. 95  
growth:  177. 73 % 31. 58 % 29. 69 %
earnings high:  0. 00   1. 20   1. 73  
earnings avg:  -0. 02   1. 11   1. 59  
earnings low:  -0. 05   1. 01   1. 47  
revenue high:  10. 50 M 9. 82 B 11. 80 B
revenue avg:  8. 77 M 9. 66 B 11. 49 B
revenue low:  7. 70 M 9. 42 B 11. 23 B
return on assets:  -7. 88 % 6. 43 % 5. 25 %
return on equity:  -38. 88 % 19. 30 % 14. 51 %
revenue growth:  67. 70 % 37. 23 % 61. 67 %
revenue/share:  0. 50   15. 89   63. 85  

beta (1yr vs S&P500):  0. 44   0. 66   0. 81  
sharpe (1yr):  2. 45   1. 84   2. 01  

held % insiders:  27. 31 % 1. 79 % 3. 24 %
held % institutions:  10. 11 % 54. 33 % 68. 91 %

Research more with google or yahoo!
The data below are updated and re-published
at 9pm EDT after each trading day.

2020-01-23 : VERU
.    125.003 =  125.003 :: INIT WEIGHT
.     --> FUNDAMENTALS <--
.    x 0.865 =  108.2   :: P/E
.     x 1.65 =  178.4   :: PE/G
.    x 1.419 =  253.2   :: beta
.    x 2.454 =  621.4   :: sharpe
.     x 1.74 =    1.1 K :: current ratio
.    x 0.973 =    1.1 K :: quick ratio
.    x 2.326 =    2.4 K :: short ratio
.     x 1.51 =    3.7 K :: revenue growth
.    x 0.993 =    3.7 K :: EV/R
.    x 1.101 =    4.0 K :: price-to-book
.    x 1.815 =    7.3 K :: debt-to-revenue
.    x 1.795 =   13.2 K :: debt-to-equity
.      --> PERFORMANCE <--
.    x 3.243 =   42.7 K :: sec+ind 1yr gains
.    x 1.123 =   47.9 K :: ind 12wk return
.    x 1.313 =   62.9 K :: ind 2wk return
.    x 14.47 =  910.4 K :: 1yr gains+div
.     x 4.86 =    4.4 M :: 13wk performance
.    x 2.987 =   13.2 M :: 5d avg > 200d avg
.    x 3.198 =   42.3 M :: 5d avg > 50d avg
.    x 1.309 =   55.3 M :: 50d avg > 200d avg
.    x 0.877 =   48.5 M :: "drift" 1 days ago
.    x 0.952 =   46.2 M :: "drift" 5 days ago
.    x 0.976 =   45.1 M :: "drift" 8 days ago
.    x 4.184 =  188.8 M :: overall "drift"
.    x 0.916 =  172.9 M :: largest delta
.     x 3.34 =  577.4 M :: volatility
.      x 2.9 =    1.7 B :: 42-day volatility
.   x 12.255 =   20.5 B :: performance
.    x 9.146 =  187.7 B :: vs s&p500
.    x 3.052 =  572.9 B :: inverse vol/price
.      --> PROJECTIONS <--
.    x 0.865 =  495.7 B :: fwd P/E
.    x 1.195 =  592.6 B :: ind recommendation
.    x 2.442 =    1.4 T :: recommendation
.    x 0.999 =    1.4 T :: ind hist wk 3
.    x 0.993 =    1.4 T :: target low
.    x 1.262 =    1.8 T :: target mean
.    x 1.054 =    1.9 T :: target high
.     x 3.62 =    6.9 T :: spline projection
.     --> FINAL ADJUST <--
.  quad root = 1621.449 :: make readable
.   + 80.828 = 1702.277 :: +/- sentiment
.     --> FINAL WEIGHT <--
.              1702.277 :: FINAL WEIGHT VERU


 


News feed RSS items generated from finance.google.com

News feed formatting by feed2js.org